<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thirty-eight eyes were treated by adding <z:chebi fb="0" ids="39465">timolol</z:chebi> to the medical regimen </plain></SENT>
<SENT sid="1" pm="."><plain>After a suitable trial, attempts were made to reduce other <z:hpo ids='HP_0000501'>glaucoma</z:hpo> medications </plain></SENT>
<SENT sid="2" pm="."><plain>Fifteen eyes with infantile <z:hpo ids='HP_0000501'>glaucoma</z:hpo> treated surgically at birth, experienced elevated intraocular pressure later in life </plain></SENT>
<SENT sid="3" pm="."><plain>Another 15 eyes had <z:hpo ids='HP_0000501'>glaucoma</z:hpo> associated with congenital anomalies such as <z:hpo ids='HP_0000526'>aniridia</z:hpo>, <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e>, and mesodermal malformations </plain></SENT>
<SENT sid="4" pm="."><plain>The group with infantile <z:hpo ids='HP_0000501'>glaucoma</z:hpo> demonstrated an average drop in pressure of 24% and 22% after one and three months, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Six of the 15 eyes were controlled at 22 mm Hg or less </plain></SENT>
<SENT sid="6" pm="."><plain>In the other group, intraocular pressure fell 30% after one month and 12% after three months </plain></SENT>
<SENT sid="7" pm="."><plain>Five of the 15 eyes were controlled </plain></SENT>
<SENT sid="8" pm="."><plain>Adverse effects occurred in five patients, <z:chebi fb="0" ids="39465">timolol</z:chebi> therapy was discontinued in two (7%) </plain></SENT>
<SENT sid="9" pm="."><plain>The IOP was not controlled in any of the eyes with <z:chebi fb="0" ids="39465">timolol</z:chebi> alone </plain></SENT>
</text></document>